Rural Health
Resources by Topic: Substance use and misuse
Impact of Alcohol Use Disorder on Inpatient Hospitalizations: A Comparison of Outcomes Between Urban and Rural Veterans Affairs Hospitals
Analyzes Veterans Health Administration hospital admissions data from 2016 to 2020 to determine the burden of alcohol use disorder on 129 rural and urban hospitals. Data shows break down of patient characteristics, hospital characteristics, and admissions characteristics. Discusses mortality and the potential impact of COVID-19.
Author(s): James Willey, Peter Kaboli, Andrea Holcombe, et al.
Citation: Journal of Hospital Medicine, 20(5), 463-470
Date: 05/2025
view details
Analyzes Veterans Health Administration hospital admissions data from 2016 to 2020 to determine the burden of alcohol use disorder on 129 rural and urban hospitals. Data shows break down of patient characteristics, hospital characteristics, and admissions characteristics. Discusses mortality and the potential impact of COVID-19.
Author(s): James Willey, Peter Kaboli, Andrea Holcombe, et al.
Citation: Journal of Hospital Medicine, 20(5), 463-470
Date: 05/2025
view details
Pain in the Nation 2025: The Epidemics of Alcohol, Drug, and Suicide Deaths
Report focuses on alcohol, drug, and mortality statistics and trends, with a special feature on polysubstance use and drug overdose issues. Includes data on substance use and mortality, with U.S. maps showing overdose and suicide rates, breakdowns according to metro versus nonmetro location, and state-by-state statistical trends. Provides policy recommendations to address substance use and offers examples from rural areas.
Date: 05/2025
Sponsoring organization: Trust for America's Health
view details
Report focuses on alcohol, drug, and mortality statistics and trends, with a special feature on polysubstance use and drug overdose issues. Includes data on substance use and mortality, with U.S. maps showing overdose and suicide rates, breakdowns according to metro versus nonmetro location, and state-by-state statistical trends. Provides policy recommendations to address substance use and offers examples from rural areas.
Date: 05/2025
Sponsoring organization: Trust for America's Health
view details
Behavioral Health Epidemiologic Profile 2024: Rural Region, Nevada
Reports on behavioral health as of 2024 in Nevada's rural Elko, Eureka, Humboldt, Lander, Pershing, and White Pine counties. Includes general population statistics with detailed data on mental health, suicide, and substance use. Highlights topics in youth behavioral health and substance use among pregnant Nevadans.
Date: 04/2025
Sponsoring organization: Nevada Department of Health and Human Services
view details
Reports on behavioral health as of 2024 in Nevada's rural Elko, Eureka, Humboldt, Lander, Pershing, and White Pine counties. Includes general population statistics with detailed data on mental health, suicide, and substance use. Highlights topics in youth behavioral health and substance use among pregnant Nevadans.
Date: 04/2025
Sponsoring organization: Nevada Department of Health and Human Services
view details
Opioid Stewardship Programs in Rural Arizona
Provides an overview of Opioid Stewardship Programs (OSPs), and discusses OSP implementation and knowledge in Arizona from a survey of 39 Arizona rural hospital leaders and professionals. Includes an infographic on the results of the OSP survey and links to OSP training resources.
Author(s): Bridget S. Murphy
Date: 04/2025
Sponsoring organization: Arizona Center for Rural Health
view details
Provides an overview of Opioid Stewardship Programs (OSPs), and discusses OSP implementation and knowledge in Arizona from a survey of 39 Arizona rural hospital leaders and professionals. Includes an infographic on the results of the OSP survey and links to OSP training resources.
Author(s): Bridget S. Murphy
Date: 04/2025
Sponsoring organization: Arizona Center for Rural Health
view details
Controlled Substance Prescribing Patterns Among Fatal Overdose Decedents with an Opioid, Stimulant, or Both Contributing to Death — Pennsylvania, 2017–2022
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on deaths involving opioids without stimulants, deaths involving stimulants without opioids, and deaths involving both opioids and stimulants in Pennsylvania between 2017 and 2022. Includes data for rural and urban areas. Discusses the role of opioid prescribing on overdose deaths.
Author(s): Stephanie Hayden, Stanley M. Murzynski, Ashley Bolton, Carrie Thomas Goetz
Citation: MMWR (Morbidity and Mortality Weekly Report), 74(12), 205-209
Date: 04/2025
Sponsoring organization: Centers for Disease Control and Prevention
view details
The Rural and Urban Supply of Clinicians With a DEA Waiver to Prescribe Buprenorphine in 2022 Prior to the Elimination of the Waiver Requirement
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Report explores the differences in rates of clinicians with DEA waivers to prescribe buprenorphine in 2022 in rural versus urban counties. Highlights the rural gaps in access to buprenorphine to treat opioid use disorder prior to the elimination of the DEA waiver requirement in 2023. Provides rural, urban, and regional comparisons.
Date: 04/2025
Sponsoring organization: WWAMI Rural Health Research Center
view details
Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs
Examines availability of methadone at opioid treatment programs for Medicare beneficiaries who have been diagnosed with an opioid use disorder. Utilizes data from 640,706 Medicare beneficiaries and analyzes their respective drive time to a treatment facility as well as receipt of methadone treatment. Includes U.S. map showing locations of opioid treatment programs and rural versus urban comparisons of patient drive times.
Author(s): Jonathan Cantor, Helin G. Hernandez, Aaron Kofner, et al.
Citation: JAMA Network Open, 8(4)
Date: 04/2025
view details
Examines availability of methadone at opioid treatment programs for Medicare beneficiaries who have been diagnosed with an opioid use disorder. Utilizes data from 640,706 Medicare beneficiaries and analyzes their respective drive time to a treatment facility as well as receipt of methadone treatment. Includes U.S. map showing locations of opioid treatment programs and rural versus urban comparisons of patient drive times.
Author(s): Jonathan Cantor, Helin G. Hernandez, Aaron Kofner, et al.
Citation: JAMA Network Open, 8(4)
Date: 04/2025
view details
Barriers and Facilitators to Scaling up Medications for Opioid Use Disorder in Kentucky: Qualitative Perspectives of Treatment Organization Staff
Examines perspectives from substance use treatment program staff related to the barriers and facilitators of medications for opioid use disorder (MOUD) utilization. Provides qualitative feedback data from agency staff in Kentucky and discusses organizational, patient, and community factors that impact MOUD utilization. Includes perspectives from rural areas.
Author(s): Hannah K. Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 20, 15
Date: 04/2025
view details
Examines perspectives from substance use treatment program staff related to the barriers and facilitators of medications for opioid use disorder (MOUD) utilization. Provides qualitative feedback data from agency staff in Kentucky and discusses organizational, patient, and community factors that impact MOUD utilization. Includes perspectives from rural areas.
Author(s): Hannah K. Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Citation: Substance Abuse Treatment, Prevention, and Policy, 20, 15
Date: 04/2025
view details
Different Forms of Stigma and Rural Primary Care Professionals' Willingness to Prescribe Buprenorphine
Presents a study exploring the different types of stigma affecting buprenorphine and other medications for opioid use disorder (MOUD) prescribing rates in rural primary care settings. Details perceived stigmas around MOUD by providers, such as the fear of being harmed by patients, fear of their professional image being harmed, and the fear of the medications harming their patients.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Sean Bogart, et al.
Citation: Journal of Substance Use & Addiction Treatment, 171, 209633
Date: 04/2025
view details
Presents a study exploring the different types of stigma affecting buprenorphine and other medications for opioid use disorder (MOUD) prescribing rates in rural primary care settings. Details perceived stigmas around MOUD by providers, such as the fear of being harmed by patients, fear of their professional image being harmed, and the fear of the medications harming their patients.
Author(s): Berkeley Franz, Lindsay Y. Dhanani, Sean Bogart, et al.
Citation: Journal of Substance Use & Addiction Treatment, 171, 209633
Date: 04/2025
view details
Impact of Recent Methamphetamine Use on Treatment Outcomes Among Individuals Initiating Medications for Opioid Use Disorders in Rural Treatment Settings: A 1-Year Retrospective Cohort Study
Explores the predictive role that methamphetamine urinalysis (UA) results in rural MOUD treatment intake has on methamphetamine and opioid use over time. Discusses the rise of co-use of opioids and methamphetamine and explores indicators for clinicians providing MOUD treatment.
Author(s): Leslie A Kenefick, Lisa Khairy, Luke Hall, et al.
Citation: Rural and Remote Health, 25(2), 9536
Date: 04/2025
view details
Explores the predictive role that methamphetamine urinalysis (UA) results in rural MOUD treatment intake has on methamphetamine and opioid use over time. Discusses the rise of co-use of opioids and methamphetamine and explores indicators for clinicians providing MOUD treatment.
Author(s): Leslie A Kenefick, Lisa Khairy, Luke Hall, et al.
Citation: Rural and Remote Health, 25(2), 9536
Date: 04/2025
view details